Neurology 1109 - Neurology Alert - Sep 01, 2007

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Matthew Fink, MD
Vice Chairman
Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork-Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman
Department of Neurology
Cornell University Medical College
New York, NY

Author
Norman Latov, MD, PhD
Professor of Neurology and Neuroscience
Weill Medical College of Cornell University

Assistant Editors
Michael Rubin, MD
Professor of Clinical Neurology
NewYork Presbyterian Hospital
Cornell Campus

Claire Henchcliffe, MD, DPhil
Assistant Professor
Department of Neurology
Weill Medical College
Cornell University

Dara G. Jamieson, MD
Associate Professor
Clinical Neurology Director
Weill Medical College;
Cornell University

Dana Leifer, MD
Associate Professor
Clinical Neurology
Weill Medical College
Cornell University

Subjects:

  • Eosinophilic Neuropathy — Is It In Your Skin?
  • Predicting ALS Progression
  • Prognosis and Neurological Outcomes after Aneurysmal Subarachnoid Hemorrhage
  • Levodopa Response and Prognosis in Parkinson's Disease
  • Neuroimaging in the Evaluation of Headaches During Pregnancy
  • Paroxysmal Atrial Fibrillation: An Underdiagnosed Cause of Stroke?

Objectives:

  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's physician editor, Matthew Fink, MD, reports no consultant, stockholder, speaker's bureau, research, or other relationships related to this field of study. Peer reviewer M. Flint Beal, MD, reports no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company having ties to this field of study. Author Norman Latov, MD, PhD is a consultant for Quest Diagnostics and a stockholder in Therapth. Assistant editor Michael Rubin, MD is on the speaker's bureau for Athena Diagnostics, and does research for Pfizer and Merck. Assistant editors Claire Henchcliffe, MD, DPhil and Dana Leifer, MD report no financial relationships to this field of study. Assistant editor Dara G. Jamieson, MD is a consultant for Boehringer Ingelheim and Merck, and is on the speaker's bureau for Boehringer Ingelheim, Merck, Ortho-McNeil, and Pfizer.

Copyright 2007 AHC Media. All rights reserved.